Sreekanth Puttachary

Assistant Professor, Department of Biomedical Sciences

Even after a century of research to find a cure epilepsy still remains a disease that is not well understood. Dr. Sreekanth Puttachary’s lab is focused on investigating the effect of drugs that target the endocannabinoid system (such as Cannabidiol) administered during epileptogenesis to validate their short-term and long-term impact on the disease progression. In simple terms, seizures are just the symptoms/manifestation of a disease referred to as epilepsy. People of all ages, gender, socio-economic background and demography are susceptible to this disease. More than 2.9 million people in the US suffer from epilepsy.